U.S. Bancorp heads into its July 16 Q2 earnings print with the most concentrated burst of analyst target-raising in months — and options traders rotating away from defensive hedges at the same time.
The Street has been unusually active on USB this week. Jefferies delivered the most directional move, upgrading from Hold to Buy and lifting its target from $60 to $75 — the highest on the current board. Raymond James reinstated at Strong Buy with a $72 target. JPMorgan raised its target from $57.50 to $65 while keeping an Underweight rating, and Wells Fargo's Mike Mayo moved from $62 to $66 on an Overweight. UBS lifted its target from $58 to $66 but held at Neutral. Six analysts raised targets in three days, nearly all citing a better-than-feared Q1 print and revised NII expectations. The consensus sits at Buy, with a mean target of $67.24 — about 7% above the current $62.89. The bull case rests on improving credit quality, potential Category II bank designation by 2027, and growing fee income. Bears point to flat NII guidance, lower reported noninterest income, and a reserve build tied to a new partnership dragging on near-term ROE.
Positioning tells a relaxed story. Short interest is modest at 1.7% of the float — low enough that short pressure is not a meaningful factor. Borrow availability is effectively unlimited, with over 800 million shares available in the lending pool. Cost to borrow ticked up 32% over the week to 0.51%, but the absolute level remains trivially low for a large-cap bank. None of this points to squeeze dynamics or unusual short-side conviction. Options confirm the drift toward optimism: the put/call ratio has dropped to 0.67, well below its 20-day average of 0.76 and closing in on the 52-week low of 0.55. That is nearly one standard deviation below the recent mean — a meaningful shift in tone from late May and early June, when the PCR was running above 0.85.
The stock has responded to the analyst activity. USB is up 4.1% on the week and 12.9% over the past month, trading at $62.89. The P/E has expanded to roughly 11.5x, with the multiple up about 1.5 turns over 30 days. The price-to-book has moved to 1.48x, up 0.17 over the same period. On factor rankings, USB scores well on dividends (99th percentile) and days-to-cover (75th percentile), while EPS momentum is firm at the 73rd percentile on a 30-day basis. The short score has been drifting lower all week — from 32.4 on July 1 to 31.9 on July 7 — consistent with a stock where short-side pressure is easing rather than building. Peers broadly moved in the same direction: PNC added nearly 3% on the week, CFG rose 1.9%, and KEY gained around 1%. USB's 4.1% week outpaced the group, suggesting some of the analyst-driven re-rating is specific rather than just sector beta.
On the insider side, the most recent recorded activity runs through early May. The CTO sold roughly $1.9 million in shares at $55.52 on May 5, and the Executive Chairman sold $4.6 million in early March at $54.66. All trades were sells, though they occurred at prices well below today's level. No buying has been reported in the window. The 90-day net figure is technically positive at around 357,000 shares, but that appears to reflect option exercises rather than open-market conviction. The signal is neutral.
Q2 earnings on July 16 are the natural focal point. The last comparable Q1 print produced a modest 1-day gain of 0.99% and a 5-day gain of 0.46% — a muted reaction despite the beat. With six analysts raising targets in the week before the event and the stock already up 13% over the past month, what the market is watching is less whether USB can repeat the Q1 beat and more whether management's NII guidance for the second half gives the Street reason to sustain these re-rated multiples.
See the live data behind this article on ORTEX.
Open USB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
